Data / Drug companies / Sulfamethoxazole and trimethoprim
Sulfamethoxazole and trimethoprim: 48 companies and 103 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sulfamethoxazole and trimethoprim is listed in the FDA National Drug Code Directory by 48 companies, with 103 products in commercial distribution. 97 of the products (94.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; suspension; injection, solution, concentrate, and the newest product started marketing on July 9, 2026.
The request: Get every company that lists sulfamethoxazole and trimethoprim in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 48
- Products
- 103
- Generic (ANDA) products
- 97 (94.2%)
- Application numbers
- 13
- Routes
- Oral, Intravenous
- Brand names
- Sulfatrim, Bactrim, Bactrim DS
- openFDA record search
- api.fda.gov
Companies that list sulfamethoxazole and trimethoprim
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 19 | tablet; suspension | Generic drugs (ANDA) | September 13, 2010 |
| Teva Parenteral Medicines, Inc. | 6 | injection, solution, concentrate | Generic drugs (ANDA) | August 15, 2024 |
| Chartwell RX, LLC | 4 | suspension; tablet | Generic drugs (ANDA) | January 25, 2007 |
| Remedyrepack Inc. | 4 | tablet | Generic drugs (ANDA) | July 18, 2022 |
| Advanced Rx of Tennessee, LLC | 3 | tablet | Generic drugs (ANDA) | September 13, 2010 |
| Aurobindo Pharma Limited | 3 | tablet; suspension | Generic drugs (ANDA) | June 8, 2010 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| Preferred Pharmaceuticals Inc. | 3 | suspension; tablet | Generic drugs (ANDA) | March 14, 2024 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | September 13, 2010 |
| Somerset Therapeutics, LLC | 3 | injection, solution, concentrate | Generic drugs (ANDA) | August 29, 2019 |
| American Health Packaging | 2 | tablet; suspension | Generic drugs (ANDA) | November 7, 2024 |
| Amneal Pharmaceuticals LLC | 2 | tablet | Generic drugs (ANDA) | September 13, 2010 |
| Amneal Pharmaceuticals of New York LLC | 2 | tablet | Generic drugs (ANDA) | September 13, 2010 |
| AvKARE | 2 | tablet | Generic drugs (ANDA) | August 5, 2015 |
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | March 23, 2026 |
| Cronus Pharma LLC | 2 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | March 23, 2023 |
| NuCare Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| Pai Holdings, LLC DBA Pai Pharma | 2 | suspension | New drug applications (NDA) | August 5, 2024 |
| Rising Pharma Holdings, Inc. | 2 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| Sun Pharmaceutical Industries, Inc | 2 | tablet | New drug applications (NDA) | November 1, 2004 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet | Generic drugs (ANDA) | August 25, 1986 |
| Vista Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | August 22, 2006 |
| Ani Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | February 8, 2022 |
| Asclemed USA, Inc. | 1 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| Atlantic Biologicals Corp. | 1 | suspension | Generic drugs (ANDA) | October 4, 2017 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | September 23, 2014 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | September 13, 2010 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | suspension | Generic drugs (ANDA) | January 24, 2007 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | May 11, 2026 |
| Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | February 12, 2020 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | August 25, 1986 |
| Kesin Pharma Corporation | 1 | suspension | Generic drugs (ANDA) | July 5, 2022 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | September 13, 2010 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | November 6, 2025 |
| Pharmasource Meds, LLC | 1 | tablet | Generic drugs (ANDA) | February 28, 2023 |
| Prasco Laboratories | 1 | suspension | Generic drugs (ANDA) | July 5, 2022 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| QPharma, Inc. | 1 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| Quality Care Products, LLC | 1 | tablet | Generic drugs (ANDA) | May 4, 2018 |
| Redpharm Drug | 1 | tablet | Generic drugs (ANDA) | September 13, 2010 |
| Sportpharm LLC | 1 | tablet | Generic drugs (ANDA) | February 16, 2010 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | June 22, 2022 |
| Unit Dose Solutions, Inc. | 1 | tablet | Generic drugs (ANDA) | July 9, 2026 |
| Verityrx, LLC | 1 | tablet | Generic drugs (ANDA) | February 16, 2010 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 79 | 76.7% |
| Suspension | 15 | 14.6% |
| Injection, solution, concentrate | 9 | 8.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 97 | 94.2% |
| New drug applications (NDA) | 6 | 5.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Dihydrofolate Reductase Inhibitor Antibacterial | 103 |
| Sulfonamide Antimicrobial | 103 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.